Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 1.000 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.537 | |
| 2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.535 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.517 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.513 | |
| 3qri | 919 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.495 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.494 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.490 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.489 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.489 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.484 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.482 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.479 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.479 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.478 | |
| 2hzi | JIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.478 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
| 1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.476 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.476 | |
| 4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.475 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.474 | |
| 2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.473 | |
| 2ofv | 242 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.473 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.472 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.472 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.470 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.469 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.468 | |
| 4af3 | VX6 | Aurora kinase B | 2.7.11.1 | 0.468 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.467 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.466 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.466 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
| 3nx4 | NAP | Putative oxidoreductase | / | 0.466 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.466 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.465 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.465 | |
| 1f4g | TP4 | Thymidylate synthase | / | 0.464 | |
| 3g0f | B49 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.464 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.463 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.463 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.462 | |
| 1kzj | CB3 | Thymidylate synthase | / | 0.461 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.461 | |
| 4bcr | WY1 | Peroxisome proliferator-activated receptor alpha | / | 0.461 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
| 1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.460 | |
| 2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.460 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.459 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 4jqh | 1MF | Alr2278 protein | / | 0.457 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.457 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.456 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.456 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.456 | |
| 1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.455 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.455 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.455 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.454 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 3fl8 | RAR | Dihydrofolate reductase | / | 0.453 | |
| 2c0c | NAP | Prostaglandin reductase 3 | 1 | 0.452 | |
| 2d4v | NAD | Isocitrate dehydrogenase [NADP] | / | 0.452 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.452 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.452 | |
| 4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.452 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.452 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.452 | |
| 1f12 | 3HC | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.451 | |
| 1f4f | TP3 | Thymidylate synthase | / | 0.451 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.451 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.450 | |
| 2fzw | NAD | Alcohol dehydrogenase class-3 | 1.1.1.1 | 0.450 | |
| 4cax | 646 | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.450 | |
| 4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.450 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.450 | |
| 1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
| 2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.449 | |
| 3a1n | NAD | NDP-sugar epimerase | / | 0.449 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.449 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.449 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.449 | |
| 1ppj | ANY | Cytochrome b | / | 0.448 | |
| 2wyv | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.448 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.448 | |
| 3tvu | B37 | Acetyl-CoA carboxylase | / | 0.448 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.448 | |
| 1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.447 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
| 2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.447 | |
| 3tda | PN0 | Cytochrome P450 2D6 | / | 0.447 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.447 | |
| 4cnj | FAD | L-amino acid oxidase | / | 0.447 | |
| 4ez8 | DHF | Thymidylate synthase | 2.1.1.45 | 0.447 | |
| 2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.446 | |
| 3flk | NAI | Tartrate dehydrogenase/decarboxylase | 1.1.1.93 | 0.446 | |
| 3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.446 | |
| 3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.446 | |
| 3vo3 | 0KF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
| 4feh | FAD | Decaprenylphosphoryl-beta-D-ribose oxidase | / | 0.446 | |
| 4jlk | 1NO | Deoxycytidine kinase | 2.7.1.74 | 0.446 | |
| 4l8u | 9AZ | Serum albumin | / | 0.446 | |
| 1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.445 | |
| 2fto | CB3 | Thymidylate synthase | / | 0.445 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 3bgx | MEF | Thymidylate synthase | / | 0.445 | |
| 4qe6 | JN3 | Bile acid receptor | / | 0.445 | |
| 1ra3 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 1zdw | FLV | Prenyltransferase | / | 0.444 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.444 | |
| 3stx | BKA | Methylketone synthase I | / | 0.444 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.444 | |
| 3zux | TCH | Transporter | / | 0.444 | |
| 4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.444 | |
| 4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.444 | |
| 5dp2 | NAP | CurF | / | 0.444 | |
| 1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
| 1fwm | CB3 | Thymidylate synthase | / | 0.443 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
| 3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.443 | |
| 4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.443 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.443 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 1t0l | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.442 | |
| 2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 2j3k | NAP | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.442 | |
| 2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.442 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 2zat | NAP | Dehydrogenase/reductase SDR family member 4 | 1.1.1.184 | 0.442 | |
| 4c2z | 646 | Glycylpeptide N-tetradecanoyltransferase 1 | / | 0.442 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.442 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 4irn | FAD | AnaB | / | 0.442 | |
| 4jay | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.442 | |
| 4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.442 | |
| 5emh | NAP | Iridoid synthase | 1.3.1.99 | 0.442 | |
| 1s7g | NAD | NAD-dependent protein deacylase 2 | / | 0.441 | |
| 1teh | NAD | Alcohol dehydrogenase class-3 | 1.1.1.1 | 0.441 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.441 | |
| 2w2l | NAD | D-mandelate dehydrogenase | / | 0.441 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.441 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.441 | |
| 4few | PP2 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.441 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.441 | |
| 4ly9 | 1YY | Glucokinase regulatory protein | / | 0.441 | |
| 4mih | FAD | Pyranose 2-oxidase | 1.1.3.10 | 0.441 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.441 | |
| 2b9y | FAD | Putative aminooxidase | / | 0.440 | |
| 2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.440 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.440 | |
| 2qu5 | 276 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
| 2rbe | NDP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
| 3ete | NDP | Glutamate dehydrogenase 1, mitochondrial | 1.4.1.3 | 0.440 | |
| 4g3j | VNT | Lanosterol 14-alpha-demethylase | / | 0.440 | |
| 4hvs | 647 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.440 | |
| 4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.440 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.440 |